{
  "ADD_TRANSACTION": "fr_Add Record",
  "SEQUENCE_NUM": "fr_Sequence Number",
  "DATE_SUBMITTED": "fr_Date Submitted",
  "SEQUENCE_DESCRIPT": "fr_Sequence Description",
  "IS_ACTCHANGES": "fr_Same as Regulatory Activity Contact for this Submission?",
  "PROJ_MANAGER_NAME": "fr_Name of Regulatory Project Manager, if known",
  "COMPANY_ID": "fr_Company Id",
  "DOSSIER_ID": "fr_Dossier Id",
  "DOSSIER_NAME": "fr_Dossier Name",
  "IS_ECTD": "fr_Is this an eCTD transaction?",
  "IS_SOLICITED": "fr_Is this solicited information",
  "SOLICITED_RQ": "fr_Requester of Solicited Information",
  "SOLICITED_RQ_OTHER": "fr_Other Requester Details",
  "REP_CONTACT_INFO": "Main Contact Information",
  "DATED": "fr_Dated",
  "START_DATE": "fr_Start Date",
  "END_DATE": "fr_End Date",
  "REG_ACTIVITY": "fr_Regulatory Activity",
  "REG_ACTIVITY_TYPE": "fr_Regulatory Activity Type",
  "SEQUENCE_TYPE": "fr_Sequence Description",
  "VERSION_NO": "fr_Version No.",
  "BRIEF_DESC": "fr_Brief Description",
  "ADMINISTRATIVE": "fr_Administrative",
  "BENEFIT_RISK_ASSESS": "fr_Benefit Risk Assessment",
  "CANCEL_LETTER": "fr_Cancellation Letter",
  "CHANGE_TO_DIN": "fr_Change to DIN",
  "COMMENTS_NOC": "fr_Comments on Notice of Decision",
  "COMMENTS_SUMMARY_BASIS": "fr_Comments on Summary Basis of Decision",
  "DIN_DISCONTINUED": "fr_Notification of Discontinued Sale (DIN Cancellation)",
  "DRUG_NOTIF_FORM": "fr_Drug Notification Form",
  "FOR_PERIOD": "fr_For Period",
  "INITIAL": "fr_INITIAL",
  "MEETING_MINUTES": "fr_Minutes of Meeting",
  "NOTIFICATION_CHANGE": "fr_Notification of Change in benefit-risk profile",
  "NOTIFICATION_INTERRUPT_SALE":"fr_Notification Interruption of Sale",
  "PANDEMIC_APPL": "fr_Pandemic Application",
  "POST_CLEARANCE_DATA": "fr_Post Clearance Data",
  "POST_MARKET_SURV": "fr_Post Marketing Surveillance",
  "POST_NOC_CHANGE": "fr_Post NOC Change",
  "POST_AUTH_DIV1_CHANGE": "fr_Post-Authorization Division 1 Change",
  "PRESUB_MEETING_PKG": "fr_Submission Meeting Package",
  "PRESUB_MEETING_RQ": "fr_Submission Meeting Request",
  "PRIORITY_REVIEW_RQ": "fr_Priority Review Request",
  "PRISTINE_PM": "fr_Pristine PM",
  "PRISTINE_PM_2LANG": "fr_Pristine PM - Second Language",
  "ADVISEMENT_LETTER_RESPONSE": "fr_Response to Advisement Letter ",
  "CLIN_CLARIF_RESPONSE": "fr_Response to Clinical Clarification Request ",
  "EMAIL_RQ_RESPONSE": "fr_Response to e-mail Request ",
  "LABEL_CLARIF_RESPONSE": "fr_Response to Labeling Clarification Request",
  "MHPD_RQ_RESPONSE": "fr_Response to MHPD Requests",
  "NOC_RESPONSE": "fr_Response to NOC/c-QN",
  "NOD_RESPONSE": "fr_Response to NOD",
  "NON_RESPONSE": "fr_Response to NON",
  "PROCESSING_CLARIF_RESPONSE": "fr_Response to Processing Clarification Request",
  "QUAL_CLIN_CLARIF_RESPONSE": "fr_Response to Quality and Clinical Clarification Request",
  "QUAL_CLARIF_RESPONSE": "fr_Response to Quality Clarification Request",
  "SCREENING_ACCEPT_RESPONSE": "fr_Response to Screening Acceptance Letter",
  "SCREENING_CLARIF_RESPONSE": "fr_Response to Screening Clarification Request",
  "SDN_RESPONSE": "fr_Response to SDN",
  "RECON_DECIS_LTR_INTENT": "fr_Reconsideration of Decision - Letter of Intent",
  "RECON_DECIS_RQ_RECON":  "fr_Reconsideration of Decision - Request for Reconsideration",
  "RECON_DECIS_OTHER_INFO": "fr_Reconsideration of Decision - Other Information",
  "LABEL_PREAPPROVAL_2LANG":"fr_Second Language Label - Pre-Approval",
  "PHONE_RQ_RESPONSE": "fr_Response to Telephone Request",
  "RISK_COMMUN_DOC": "fr_Risk communication document",
  "RMP_VERSION_DATE": "fr_RMP version number",
  "SIGNAL_WORK_UP": "fr_Signal Work Up",
  "UNSOLICITED_DATA": "fr_Unsolicited Data",
  "YEAR_LIST_OF_CHANGE": "fr_Year, list of change number (for example: 2012, 15, 19a,….)",
  "BE_CLARIF_RESPONSE": "fr_Response to BE Clarification Request",
  "LIFECYCLE_TITLE": "fr_Lifecycle Management Table",
  "REG_CONTACT_THIS": "fr_Regulatory Activity Contact for THIS transaction",
  "REG_ACT_CONTACT": "fr_Regulatory Activity Contact",
  "TRANSACTION_HDING": "fr_Regulatory Transaction Enrolment",
  "LOAD_TRANSACTION": "fr_Load a Regulatory Transaction Enrolment File",
  "GENERATE_FINAL": "fr_Generate Final XML",
  "CONTACT_SAME": "fr_I confirm that the above regulatory activity contact information is  valid.",
  "YEAR_CHANGE": "fr_Year of the change, List Description",
  "COMPANY_INFO": "A. Company Information",
  "ADDRESS_INFO": "B. Address Information",
  "COMPANY_REP_THIS": "C. Company Representative",
  "REG_ACTIVITY_INSTRUCT":"fr_Regulatory Activity Contact Instructions",
  "SAVE_INSTRUCT": "fr_Transaction File Save Instructions",
  "CLARIF_RESPONSE":"fr_Response to Clarification Request",
  "NONCLIN_CLARIF_RESPONSE": "fr_Response to Non-clinical Clarification Request ",
  "CORR_PATENT_MED":"fr_Correspondence - Patented Medicines",
  "ALLEGATION_NOTICE":"fr_Notice of allegation",
  "FORM_IV":"fr_Form IV",
  "FORM_V":"fr_Form V",
  "CONSENT_LTR":"fr_Consent Letter",
  "DATA_PROTECT_CORRESP":"fr_Correspondence - Data Protection",
  "CHOOSE_REQUEST":"fr_Choose a requester",
  "TRANSACT_INSTRUCT":"fr_Regulatory Transaction Instructions",
  "LIST_DESCRIPT":"fr_List Description",
  "SEQUENCE_CLEANUP":"fr_Sequence Clean-up",
  "FEE_REMISSION":"fr_Fee Remission is requested with this transaction",
  "STATEMENT_REVENUE":"fr_A statement signed by the individual responsible for the applicant's financial affairs is included to certify that the fee payable is greater than 10% of the anticipated gross revenue",
  "DEFER_INSTRUCT":"fr_Deferral of payment Instructions",
  "REMISSION_INSTRUCT":"fr_Fee remission Instructions",
  "CLASS_INSTRUCT":"fr_Submission Class Instructions",

  "PLEASE_REMIT":"fr_Please include the remission processing fee of $566.",
  "APPLY_DEFER":"fr_You are applying for a deferral. Please send no payment with this form.",
  "BANK_DRAFT":"fr_International Bank Draft",
  "MONEY_ORDER":"fr_Money Order",
  "CHEQUE":"fr_Cheque",
  "CREDIT":"fr_Mastercard / Visa / Amex / Visa Debit / JCB International",
  "BANK_WIRE":"fr_Wire (include bank confirmation)",
  "EXISTING_CREDIT":"fr_Existing credit",
  "PREFEERED_OPTION":"fr_Bill Payment Service Option (preferred method)",
  "SUPPORTING_DOC":"fr_Please include the required signed statement AND at least one of the support documentation to establish that the applicable fee payable is greater than 10% of the anticipated gross revenue from sales of the drug product in Canada during the fee verification period.",
  "REG_TRANSACT":"fr_Regulatory Transaction",
  "LIFE_REC":"fr_Lifecycle Record",
  "ONELIFEREC": "Un enregistrement de cycle de vie est nécessaire",
  "LIFECYCLECTRL.LIFECYCLEDETAILSFORM":"fr_with a Lifecycle Record",
  "OTHER_DOC_DETAILS": "fr_Other Documentation Details"

}